Schonfeld Strategic Advisors’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-50,000
| Closed | -$798K | – | 2190 |
|
|
2024
Q3 | $798K | Buy |
+50,000
| New | +$798K | 0.01% | 1106 |
|
|
2022
Q4 | – | Sell |
-510
| Closed | -$25K | – | 2834 |
|
|
2022
Q3 | $25K | Buy |
+510
| New | +$25K | ﹤0.01% | 2634 |
|
|
2020
Q3 | – | Sell |
-1,683
| Closed | -$143K | – | 1555 |
|
|
2020
Q2 | $143K | Buy |
+1,683
| New | +$143K | ﹤0.01% | 1104 |
|
|
2020
Q1 | – | Sell |
-607
| Closed | -$43K | – | 1450 |
|
|
2019
Q4 | $43K | Buy |
+607
| New | +$43K | ﹤0.01% | 1233 |
|
|
2018
Q4 | – | Sell |
-2,000
| Closed | -$933K | – | 1205 |
|
|
2018
Q3 | $933K | Buy |
+2,000
| New | +$933K | 0.04% | 441 |
|
|
2016
Q3 | – | Sell |
-1,562
| Closed | -$656K | – | 521 |
|
|
2016
Q2 | $656K | Buy |
+1,562
| New | +$656K | 0.15% | 190 |
|